Lv31
388 积分 2023-05-29 加入
The Use of Physiology-Based Pharmacokinetic and Pharmacodynamic Modeling in the Discovery of the Dual Orexin Receptor Antagonist ACT-541468
2小时前
已完结
AGA Clinical Practice Guideline on the Role of Biomarkers for the Management of Crohn’s Disease
5天前
已完结
Su1895: CD64 BINDING IS UNLIKELY TO CONTRIBUTE TO THE CLINICAL EFFICACY OF IL-23 INHIBITORS IN IBD
10天前
已关闭
Food effect trial of the pharmacokinetics and safety of TQ05105 in healthy Chinese subjects
13天前
已完结
Efficacy and safety of intravenous induction and subcutaneous maintenance therapy with guselkumab for patients with Crohn's disease (GALAXI-2 and GALAXI-3): 48-week results from two phase 3, randomised, placebo and active comparator-controlled, double-blind, triple-dummy trials
16天前
已完结
Letter: immunogenicity is not the root cause for loss of response to anti‐TNF agents in patients with IBD in TDM era
17天前
已完结
Efficacy of Tyrosine Kinase Inhibitors in Third Line Therapy in Chronic Phase Chronic Myeloid Leukemia
22天前
已关闭
JAK2 Rearrangements Are a Recurrent Alteration in CD30+ Systemic T-Cell Lymphomas With Anaplastic Morphology
28天前
已完结
围术期醋酸盐平衡晶体液临床应用专家共识
1个月前
已完结
皖公网安备34019202002308
